[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

IVD Antibodies Market, Global Outlook and Forecast 2022-2028

April 2022 | 66 pages | ID: I9058FDC33FBEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In vitro diagnostics tests are used in laboratories, healthcare settings or directly by consumers at home for the detection of various diseases, infections and other medical conditions. Various companies in the IVD antibodies market are focusing on mergers and acquisitions with regional players. For example, in Sep. 2018, Summa Equity AB acquired Turku-based HyTest Ltd. whose regional presence in the U.S. and Asia is good. Continuously evolving nature of IVD antibodies market further expected to get maximum traction. Superior capability of the IVD antibodies to detect complex diseases such as cancer and use of IVD antibodies in therapeutic monitoring, evaluating blood safety before transfusion further makes it preferred choice of diagnosis test.

This report contains market size and forecasts of IVD Antibodies in Global, including the following market information:

Global IVD Antibodies Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global IVD Antibodies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cardiac Markers Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of IVD Antibodies include Abcam, Thermo Fisher Scientific, Rockland Immunochemicals, GenScript, Bio-Rad Laboratories, SDIX, MEDICAL & BIOLOGICAL LABORATORIES, HyTest and Abbott. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IVD Antibodies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global IVD Antibodies Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global IVD Antibodies Market Segment Percentages, by Type, 2021 (%)
  • Cardiac Markers
  • Tumor Markers
  • Kidney Injury Markers
Global IVD Antibodies Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global IVD Antibodies Market Segment Percentages, by Application, 2021 (%)
  • Hospital
  • Specialty Clinic
  • Diagnostic Center
  • Others
Global IVD Antibodies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global IVD Antibodies Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies IVD Antibodies revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies IVD Antibodies revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Abcam
  • Thermo Fisher Scientific
  • Rockland Immunochemicals
  • GenScript
  • Bio-Rad Laboratories
  • SDIX
  • MEDICAL & BIOLOGICAL LABORATORIES
  • HyTest
  • Abbott
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 IVD Antibodies Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global IVD Antibodies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IVD ANTIBODIES OVERALL MARKET SIZE

2.1 Global IVD Antibodies Market Size: 2021 VS 2028
2.2 Global IVD Antibodies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top IVD Antibodies Players in Global Market
3.2 Top Global IVD Antibodies Companies Ranked by Revenue
3.3 Global IVD Antibodies Revenue by Companies
3.4 Top 3 and Top 5 IVD Antibodies Companies in Global Market, by Revenue in 2021
3.5 Global Companies IVD Antibodies Product Type
3.6 Tier 1, Tier 2 and Tier 3 IVD Antibodies Players in Global Market
  3.6.1 List of Global Tier 1 IVD Antibodies Companies
  3.6.2 List of Global Tier 2 and Tier 3 IVD Antibodies Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global IVD Antibodies Market Size Markets, 2021 & 2028
  4.1.2 Cardiac Markers
  4.1.3 Tumor Markers
  4.1.4 Kidney Injury Markers
4.2 By Type - Global IVD Antibodies Revenue & Forecasts
  4.2.1 By Type - Global IVD Antibodies Revenue, 2017-2022
  4.2.2 By Type - Global IVD Antibodies Revenue, 2023-2028
  4.2.3 By Type - Global IVD Antibodies Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global IVD Antibodies Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Specialty Clinic
  5.1.4 Diagnostic Center
  5.1.5 Others
5.2 By Application - Global IVD Antibodies Revenue & Forecasts
  5.2.1 By Application - Global IVD Antibodies Revenue, 2017-2022
  5.2.2 By Application - Global IVD Antibodies Revenue, 2023-2028
  5.2.3 By Application - Global IVD Antibodies Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global IVD Antibodies Market Size, 2021 & 2028
6.2 By Region - Global IVD Antibodies Revenue & Forecasts
  6.2.1 By Region - Global IVD Antibodies Revenue, 2017-2022
  6.2.2 By Region - Global IVD Antibodies Revenue, 2023-2028
  6.2.3 By Region - Global IVD Antibodies Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America IVD Antibodies Revenue, 2017-2028
  6.3.2 US IVD Antibodies Market Size, 2017-2028
  6.3.3 Canada IVD Antibodies Market Size, 2017-2028
  6.3.4 Mexico IVD Antibodies Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe IVD Antibodies Revenue, 2017-2028
  6.4.2 Germany IVD Antibodies Market Size, 2017-2028
  6.4.3 France IVD Antibodies Market Size, 2017-2028
  6.4.4 U.K. IVD Antibodies Market Size, 2017-2028
  6.4.5 Italy IVD Antibodies Market Size, 2017-2028
  6.4.6 Russia IVD Antibodies Market Size, 2017-2028
  6.4.7 Nordic Countries IVD Antibodies Market Size, 2017-2028
  6.4.8 Benelux IVD Antibodies Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia IVD Antibodies Revenue, 2017-2028
  6.5.2 China IVD Antibodies Market Size, 2017-2028
  6.5.3 Japan IVD Antibodies Market Size, 2017-2028
  6.5.4 South Korea IVD Antibodies Market Size, 2017-2028
  6.5.5 Southeast Asia IVD Antibodies Market Size, 2017-2028
  6.5.6 India IVD Antibodies Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America IVD Antibodies Revenue, 2017-2028
  6.6.2 Brazil IVD Antibodies Market Size, 2017-2028
  6.6.3 Argentina IVD Antibodies Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa IVD Antibodies Revenue, 2017-2028
  6.7.2 Turkey IVD Antibodies Market Size, 2017-2028
  6.7.3 Israel IVD Antibodies Market Size, 2017-2028
  6.7.4 Saudi Arabia IVD Antibodies Market Size, 2017-2028
  6.7.5 UAE IVD Antibodies Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abcam
  7.1.1 Abcam Corporate Summary
  7.1.2 Abcam Business Overview
  7.1.3 Abcam IVD Antibodies Major Product Offerings
  7.1.4 Abcam IVD Antibodies Revenue in Global Market (2017-2022)
  7.1.5 Abcam Key News
7.2 Thermo Fisher Scientific
  7.2.1 Thermo Fisher Scientific Corporate Summary
  7.2.2 Thermo Fisher Scientific Business Overview
  7.2.3 Thermo Fisher Scientific IVD Antibodies Major Product Offerings
  7.2.4 Thermo Fisher Scientific IVD Antibodies Revenue in Global Market (2017-2022)
  7.2.5 Thermo Fisher Scientific Key News
7.3 Rockland Immunochemicals
  7.3.1 Rockland Immunochemicals Corporate Summary
  7.3.2 Rockland Immunochemicals Business Overview
  7.3.3 Rockland Immunochemicals IVD Antibodies Major Product Offerings
  7.3.4 Rockland Immunochemicals IVD Antibodies Revenue in Global Market (2017-2022)
  7.3.5 Rockland Immunochemicals Key News
7.4 GenScript
  7.4.1 GenScript Corporate Summary
  7.4.2 GenScript Business Overview
  7.4.3 GenScript IVD Antibodies Major Product Offerings
  7.4.4 GenScript IVD Antibodies Revenue in Global Market (2017-2022)
  7.4.5 GenScript Key News
7.5 Bio-Rad Laboratories
  7.5.1 Bio-Rad Laboratories Corporate Summary
  7.5.2 Bio-Rad Laboratories Business Overview
  7.5.3 Bio-Rad Laboratories IVD Antibodies Major Product Offerings
  7.5.4 Bio-Rad Laboratories IVD Antibodies Revenue in Global Market (2017-2022)
  7.5.5 Bio-Rad Laboratories Key News
7.6 SDIX
  7.6.1 SDIX Corporate Summary
  7.6.2 SDIX Business Overview
  7.6.3 SDIX IVD Antibodies Major Product Offerings
  7.6.4 SDIX IVD Antibodies Revenue in Global Market (2017-2022)
  7.6.5 SDIX Key News
7.7 MEDICAL & BIOLOGICAL LABORATORIES
  7.7.1 MEDICAL & BIOLOGICAL LABORATORIES Corporate Summary
  7.7.2 MEDICAL & BIOLOGICAL LABORATORIES Business Overview
  7.7.3 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Major Product Offerings
  7.7.4 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Revenue in Global Market (2017-2022)
  7.7.5 MEDICAL & BIOLOGICAL LABORATORIES Key News
7.8 HyTest
  7.8.1 HyTest Corporate Summary
  7.8.2 HyTest Business Overview
  7.8.3 HyTest IVD Antibodies Major Product Offerings
  7.8.4 HyTest IVD Antibodies Revenue in Global Market (2017-2022)
  7.8.5 HyTest Key News
7.9 Abbott
  7.9.1 Abbott Corporate Summary
  7.9.2 Abbott Business Overview
  7.9.3 Abbott IVD Antibodies Major Product Offerings
  7.9.4 Abbott IVD Antibodies Revenue in Global Market (2017-2022)
  7.9.5 Abbott Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. IVD Antibodies Market Opportunities & Trends in Global Market
Table 2. IVD Antibodies Market Drivers in Global Market
Table 3. IVD Antibodies Market Restraints in Global Market
Table 4. Key Players of IVD Antibodies in Global Market
Table 5. Top IVD Antibodies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global IVD Antibodies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global IVD Antibodies Revenue Share by Companies, 2017-2022
Table 8. Global Companies IVD Antibodies Product Type
Table 9. List of Global Tier 1 IVD Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 IVD Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global IVD Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - IVD Antibodies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - IVD Antibodies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global IVD Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - IVD Antibodies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - IVD Antibodies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global IVD Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global IVD Antibodies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global IVD Antibodies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America IVD Antibodies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America IVD Antibodies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe IVD Antibodies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe IVD Antibodies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia IVD Antibodies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia IVD Antibodies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America IVD Antibodies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America IVD Antibodies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa IVD Antibodies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa IVD Antibodies Revenue, (US$, Mn), 2023-2028
Table 30. Abcam Corporate Summary
Table 31. Abcam IVD Antibodies Product Offerings
Table 32. Abcam IVD Antibodies Revenue (US$, Mn), (2017-2022)
Table 33. Thermo Fisher Scientific Corporate Summary
Table 34. Thermo Fisher Scientific IVD Antibodies Product Offerings
Table 35. Thermo Fisher Scientific IVD Antibodies Revenue (US$, Mn), (2017-2022)
Table 36. Rockland Immunochemicals Corporate Summary
Table 37. Rockland Immunochemicals IVD Antibodies Product Offerings
Table 38. Rockland Immunochemicals IVD Antibodies Revenue (US$, Mn), (2017-2022)
Table 39. GenScript Corporate Summary
Table 40. GenScript IVD Antibodies Product Offerings
Table 41. GenScript IVD Antibodies Revenue (US$, Mn), (2017-2022)
Table 42. Bio-Rad Laboratories Corporate Summary
Table 43. Bio-Rad Laboratories IVD Antibodies Product Offerings
Table 44. Bio-Rad Laboratories IVD Antibodies Revenue (US$, Mn), (2017-2022)
Table 45. SDIX Corporate Summary
Table 46. SDIX IVD Antibodies Product Offerings
Table 47. SDIX IVD Antibodies Revenue (US$, Mn), (2017-2022)
Table 48. MEDICAL & BIOLOGICAL LABORATORIES Corporate Summary
Table 49. MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Product Offerings
Table 50. MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Revenue (US$, Mn), (2017-2022)
Table 51. HyTest Corporate Summary
Table 52. HyTest IVD Antibodies Product Offerings
Table 53. HyTest IVD Antibodies Revenue (US$, Mn), (2017-2022)
Table 54. Abbott Corporate Summary
Table 55. Abbott IVD Antibodies Product Offerings
Table 56. Abbott IVD Antibodies Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. IVD Antibodies Segment by Type in 2021
Figure 2. IVD Antibodies Segment by Application in 2021
Figure 3. Global IVD Antibodies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global IVD Antibodies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global IVD Antibodies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by IVD Antibodies Revenue in 2021
Figure 8. By Type - Global IVD Antibodies Revenue Market Share, 2017-2028
Figure 9. By Application - Global IVD Antibodies Revenue Market Share, 2017-2028
Figure 10. By Region - Global IVD Antibodies Revenue Market Share, 2017-2028
Figure 11. By Country - North America IVD Antibodies Revenue Market Share, 2017-2028
Figure 12. US IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe IVD Antibodies Revenue Market Share, 2017-2028
Figure 16. Germany IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 17. France IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia IVD Antibodies Revenue Market Share, 2017-2028
Figure 24. China IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 28. India IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America IVD Antibodies Revenue Market Share, 2017-2028
Figure 30. Brazil IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa IVD Antibodies Revenue Market Share, 2017-2028
Figure 33. Turkey IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE IVD Antibodies Revenue, (US$, Mn), 2017-2028
Figure 37. Abcam IVD Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Thermo Fisher Scientific IVD Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Rockland Immunochemicals IVD Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GenScript IVD Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bio-Rad Laboratories IVD Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. SDIX IVD Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. HyTest IVD Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Abbott IVD Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications